Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helicobacter pylori | 10 | 2012 | 381 | 2.000 |
Why?
|
| Helicobacter Infections | 7 | 2011 | 385 | 1.520 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2020 | 161 | 1.170 |
Why?
|
| Hepatitis, Alcoholic | 2 | 2018 | 103 | 1.100 |
Why?
|
| Inflammatory Bowel Diseases | 10 | 2020 | 2410 | 0.700 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 123 | 0.700 |
Why?
|
| Hyperammonemia | 1 | 2020 | 76 | 0.670 |
Why?
|
| Gap Junctions | 1 | 2020 | 233 | 0.660 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 220 | 0.640 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 139 | 0.620 |
Why?
|
| Gastrointestinal Agents | 4 | 2020 | 494 | 0.620 |
Why?
|
| Liver Transplantation | 2 | 2018 | 2117 | 0.570 |
Why?
|
| Arteriovenous Malformations | 1 | 2020 | 396 | 0.570 |
Why?
|
| Drug Tolerance | 1 | 2018 | 375 | 0.550 |
Why?
|
| Colitis, Ulcerative | 7 | 2020 | 1901 | 0.490 |
Why?
|
| Patient Care Management | 1 | 2017 | 306 | 0.480 |
Why?
|
| Crohn Disease | 4 | 2020 | 2301 | 0.450 |
Why?
|
| Dendritic Cells | 5 | 2012 | 2723 | 0.450 |
Why?
|
| Panniculitis, Peritoneal | 1 | 2012 | 11 | 0.430 |
Why?
|
| Liver Diseases | 1 | 2020 | 1252 | 0.390 |
Why?
|
| Hepatocytes | 4 | 2020 | 1209 | 0.370 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2012 | 169 | 0.370 |
Why?
|
| DNA, Bacterial | 3 | 2012 | 1465 | 0.360 |
Why?
|
| Colitis | 3 | 2012 | 1149 | 0.330 |
Why?
|
| Biological Therapy | 2 | 2020 | 138 | 0.330 |
Why?
|
| Liver | 3 | 2020 | 7470 | 0.320 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2018 | 2211 | 0.310 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 1788 | 0.310 |
Why?
|
| Bacterial Vaccines | 1 | 2010 | 402 | 0.300 |
Why?
|
| Alcoholism | 1 | 2018 | 1904 | 0.300 |
Why?
|
| Gastric Mucosa | 1 | 2009 | 598 | 0.280 |
Why?
|
| Patient Selection | 2 | 2020 | 4214 | 0.280 |
Why?
|
| Immune Evasion | 1 | 2009 | 360 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4414 | 0.280 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2007 | 138 | 0.270 |
Why?
|
| Colectomy | 3 | 2019 | 681 | 0.260 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 4249 | 0.250 |
Why?
|
| Salvage Therapy | 1 | 2011 | 1269 | 0.240 |
Why?
|
| Drug Eruptions | 1 | 2007 | 295 | 0.230 |
Why?
|
| Interleukin-17 | 1 | 2009 | 900 | 0.230 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 654 | 0.220 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 2 | 2017 | 271 | 0.210 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 1837 | 0.200 |
Why?
|
| Recurrence | 3 | 2018 | 8333 | 0.180 |
Why?
|
| Second-Look Surgery | 1 | 2019 | 29 | 0.170 |
Why?
|
| Ammonia | 1 | 2020 | 239 | 0.170 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 418 | 0.160 |
Why?
|
| Drug Hypersensitivity | 1 | 2007 | 883 | 0.160 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 592 | 0.150 |
Why?
|
| Anti-Retroviral Agents | 1 | 2007 | 1712 | 0.150 |
Why?
|
| Interleukin-10 | 3 | 2012 | 1200 | 0.150 |
Why?
|
| Cytokines | 2 | 2012 | 7317 | 0.150 |
Why?
|
| Histocytochemistry | 1 | 2018 | 718 | 0.150 |
Why?
|
| Opportunistic Infections | 1 | 2020 | 389 | 0.140 |
Why?
|
| Drug Monitoring | 2 | 2020 | 956 | 0.140 |
Why?
|
| Alkaline Phosphatase | 1 | 2020 | 865 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 2986 | 0.140 |
Why?
|
| Hepatic Stellate Cells | 1 | 2016 | 109 | 0.130 |
Why?
|
| Fatigue | 2 | 2020 | 1526 | 0.130 |
Why?
|
| Remission Induction | 2 | 2019 | 2384 | 0.130 |
Why?
|
| Hepatic Encephalopathy | 1 | 2016 | 139 | 0.130 |
Why?
|
| Proton Pump Inhibitors | 2 | 2011 | 521 | 0.130 |
Why?
|
| Liver Failure, Acute | 1 | 2016 | 165 | 0.120 |
Why?
|
| Humans | 33 | 2020 | 742088 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2020 | 7716 | 0.120 |
Why?
|
| Radiography, Abdominal | 1 | 2018 | 537 | 0.120 |
Why?
|
| Cytosol | 1 | 2017 | 901 | 0.120 |
Why?
|
| NAD | 1 | 2017 | 594 | 0.120 |
Why?
|
| Waiting Lists | 1 | 2017 | 692 | 0.110 |
Why?
|
| Immune Tolerance | 2 | 2012 | 2257 | 0.110 |
Why?
|
| Drug Therapy, Combination | 3 | 2019 | 6483 | 0.110 |
Why?
|
| Biopsy | 2 | 2018 | 6756 | 0.110 |
Why?
|
| Methotrexate | 1 | 2019 | 1720 | 0.110 |
Why?
|
| Anti-Ulcer Agents | 2 | 2011 | 119 | 0.110 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2012 | 78 | 0.100 |
Why?
|
| Butyrates | 1 | 2012 | 163 | 0.100 |
Why?
|
| Mesentery | 1 | 2012 | 205 | 0.100 |
Why?
|
| Fatal Outcome | 2 | 2016 | 1849 | 0.100 |
Why?
|
| Intestinal Mucosa | 3 | 2012 | 3038 | 0.100 |
Why?
|
| Ethanol | 1 | 2018 | 1337 | 0.100 |
Why?
|
| Female | 18 | 2020 | 379592 | 0.100 |
Why?
|
| Interleukin-23 | 1 | 2012 | 193 | 0.100 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 668 | 0.100 |
Why?
|
| Adult | 13 | 2020 | 213712 | 0.090 |
Why?
|
| Hepatitis B | 1 | 2016 | 695 | 0.090 |
Why?
|
| Salmonella Infections, Animal | 1 | 2010 | 65 | 0.090 |
Why?
|
| Dextran Sulfate | 1 | 2011 | 236 | 0.090 |
Why?
|
| Feces | 2 | 2020 | 1394 | 0.090 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 495 | 0.090 |
Why?
|
| Male | 17 | 2020 | 349538 | 0.090 |
Why?
|
| Gram-Negative Bacteria | 1 | 2012 | 270 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1782 | 0.090 |
Why?
|
| Weight Gain | 1 | 2020 | 2282 | 0.090 |
Why?
|
| Bismuth | 1 | 2009 | 29 | 0.090 |
Why?
|
| Breath Tests | 1 | 2011 | 276 | 0.090 |
Why?
|
| Interferon-alpha | 1 | 2014 | 895 | 0.090 |
Why?
|
| Mice | 8 | 2020 | 81045 | 0.090 |
Why?
|
| Antacids | 1 | 2009 | 99 | 0.090 |
Why?
|
| Clarithromycin | 1 | 2009 | 86 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 21821 | 0.090 |
Why?
|
| Interleukins | 1 | 2014 | 791 | 0.090 |
Why?
|
| Tetracycline | 1 | 2009 | 214 | 0.080 |
Why?
|
| Hepacivirus | 1 | 2016 | 1372 | 0.080 |
Why?
|
| HIV | 1 | 2016 | 1600 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2107 | 0.080 |
Why?
|
| Interleukin-12 | 1 | 2011 | 579 | 0.080 |
Why?
|
| Amoxicillin | 1 | 2009 | 170 | 0.080 |
Why?
|
| Metronidazole | 1 | 2009 | 217 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 310 | 0.080 |
Why?
|
| Middle Aged | 9 | 2020 | 213127 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2011 | 491 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2906 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2011 | 542 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5385 | 0.070 |
Why?
|
| Echocardiography | 1 | 2020 | 5097 | 0.070 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 844 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7276 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3081 | 0.070 |
Why?
|
| Animals | 11 | 2020 | 168561 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2896 | 0.070 |
Why?
|
| Prevalence | 2 | 2020 | 15194 | 0.070 |
Why?
|
| Amifostine | 1 | 2005 | 41 | 0.070 |
Why?
|
| Radiation-Protective Agents | 1 | 2005 | 89 | 0.070 |
Why?
|
| United States | 6 | 2020 | 69693 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14554 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14720 | 0.060 |
Why?
|
| Herpes Zoster | 1 | 2007 | 264 | 0.060 |
Why?
|
| Young Adult | 3 | 2020 | 56350 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15530 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 1170 | 0.060 |
Why?
|
| Apoptosis | 1 | 2020 | 9715 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 3 | 2011 | 7153 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1969 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2014 | 1582 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2011 | 3001 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2011 | 1032 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2010 | 9941 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2020 | 40450 | 0.060 |
Why?
|
| Hospitalization | 2 | 2019 | 10232 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2012 | 4214 | 0.050 |
Why?
|
| Bone Development | 1 | 2005 | 483 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1923 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 971 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 2006 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12958 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13256 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2020 | 77098 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 2130 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2009 | 2680 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5519 | 0.040 |
Why?
|
| Sigmoidoscopy | 1 | 2019 | 156 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2007 | 1872 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 2005 | 1178 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8425 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2012 | 19223 | 0.040 |
Why?
|
| Decerebrate State | 1 | 2016 | 43 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 23387 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 392 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2012 | 18006 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 3843 | 0.030 |
Why?
|
| Time Factors | 3 | 2017 | 40054 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2011 | 9144 | 0.030 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2016 | 138 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2017 | 1161 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 162944 | 0.030 |
Why?
|
| Netherlands | 1 | 2020 | 2170 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2016 | 528 | 0.030 |
Why?
|
| Gallbladder | 1 | 2016 | 301 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57683 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2017 | 853 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 10943 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2009 | 13029 | 0.030 |
Why?
|
| Unconsciousness | 1 | 2016 | 262 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10472 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2017 | 1547 | 0.030 |
Why?
|
| Metabolome | 1 | 2020 | 881 | 0.030 |
Why?
|
| Prisoners | 1 | 2016 | 296 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2020 | 62966 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 320 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 1341 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2187 | 0.030 |
Why?
|
| Child | 1 | 2020 | 77478 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 35342 | 0.020 |
Why?
|
| Peptic Ulcer | 1 | 2011 | 223 | 0.020 |
Why?
|
| Interferons | 1 | 2014 | 704 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1575 | 0.020 |
Why?
|
| Cecum | 1 | 2010 | 237 | 0.020 |
Why?
|
| Endotoxins | 1 | 2012 | 525 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 26343 | 0.020 |
Why?
|
| Transfection | 1 | 2017 | 5892 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2016 | 859 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29010 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2010 | 841 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 72145 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 2010 | 351 | 0.020 |
Why?
|
| Metagenome | 1 | 2011 | 417 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 2500 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39004 | 0.020 |
Why?
|
| Probiotics | 1 | 2011 | 351 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2012 | 1470 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3618 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 1864 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10392 | 0.020 |
Why?
|
| Pentoxifylline | 1 | 2005 | 55 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2020 | 53187 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4147 | 0.020 |
Why?
|
| Radiography | 1 | 2016 | 7010 | 0.020 |
Why?
|
| Misoprostol | 1 | 2005 | 95 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 2513 | 0.010 |
Why?
|
| Th17 Cells | 1 | 2010 | 765 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2016 | 5978 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18355 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Colon | 1 | 2010 | 1773 | 0.010 |
Why?
|
| Cell Line | 1 | 2016 | 15994 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21719 | 0.010 |
Why?
|
| Random Allocation | 1 | 2005 | 2425 | 0.010 |
Why?
|
| Bacteria | 1 | 2011 | 2102 | 0.010 |
Why?
|
| Tibia | 1 | 2005 | 1075 | 0.010 |
Why?
|
| Comorbidity | 1 | 2014 | 10372 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 19862 | 0.010 |
Why?
|
| Risk | 1 | 2010 | 9679 | 0.010 |
Why?
|
| Lung | 1 | 2016 | 9826 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16665 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23320 | 0.010 |
Why?
|
| Knee Joint | 1 | 2005 | 1679 | 0.010 |
Why?
|
| Models, Biological | 1 | 2012 | 9581 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 8300 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 12071 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 85649 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 24265 | 0.010 |
Why?
|
Concepts
(232)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_